Market Overview

Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue

Related HSP
The Medicines Company Falls 10% Following Angiomax Court Hearing
Hospira Issues Statement on FDA Approval of First Biosimilar in US
Neogen Lags Q3 Earnings & Revenue Estimates, Stock Down - Analyst Blog (Zacks)
Related VRX
Ackman Boosts Stake In Valeant; Still Appears To Be Passive
Benzinga's M&A Chatter for Monday March 16, 2015
Hyperion Therapeutics is an attractive takeover target says analyst (Seeking Alpha)

Below are the top drug delivery stocks on the NYSE in terms of revenue.

The trailing-twelve-month revenue at Hospira (NYSE: HSP) is $4.02 billion. Hospira had $655.90 million in total cash for the latest quarter.

The trailing-twelve-month revenue at Valeant Pharmaceuticals International (NYSE: VRX) is $2.75 billion. Valeant Pharmaceuticals' operating margin for the same period is 23.99%.

The trailing-twelve-month revenue at Elan Corporation plc (NYSE: ELN) is $1.29 billion. Elan's ROE for the same period is 102.84%.

The trailing-twelve-month revenue at K-V Pharmaceutical Company (NYSE: KV-A) is $23.20 million. K-V Pharmaceutical had $50.70 million in total cash for the latest quarter.

Posted-In: Drug Delivery Industry Highest Revenue NYSETrading Ideas


Related Articles (ELN + HSP)

Around the Web, We're Loving...